Latest news from the Science Center, our resident companies and the innovation ecosystem.
October 10, 2017 | Resident & Alumni News
Stressed about renting? Whose Your Landlord offers Yelp-like reviews
In this age of information, where it’s easy to find facts and statistics about nearly anything, Temple University graduate Ofo Ezeugwu found a gap: Renters struggle to find information about landlords and their properties.
Oncora Medical raised $1.3 million to hire more tech staff
Center City health IT company Oncora Medical just announced it raised some follow-on capital to the tune of $1.3 million to build out its tech team. The realLIST company, based out of Center City, is calling the raise a Series Seed, a term that cofounder David Lindsay says is in reference to it being Oncora’s first equity financing.
VitalTrax — the clinical software platform that connects patients to clinical trials — just hit another major milestone. On Wednesday, the startup announced that its clinical trial network Wing is now on the market. The network, the company’s first commercial product, includes a mobile app and online platform for listing trials and also recruiting and enrolling patients. Because the product makes health care more consumer friendly, it’s been dubbed the “OpenTable of clinical trials.”
One Health Company balances improving biomedical research and ethical animal testing
The One Health Company, a contract research organization, understands the strong connection between pets and their owners in more ways than one. It is working to make biomedical research more efficient with a business that recognizes the similarities between certain diseases experienced by dogs and humans.
Want To Speed Biomedical Research? Do It In Dog Years
Biomedical research takes a long time… Way too long for patients anxiously waiting for treatments that can keep them alive or spare them agony. So, here is an idea. How about switching research’s typical drawn-out, excruciating timeline to dog years. Dog years?
Integral Molecular Announces Technology Advancement for Discovery of New Immuno-Oncology Therapeutic Targets
-Integral Molecular, a leader in membrane protein technologies, has initiated a therapeutic target discovery program in immuno-oncology by exploiting its Membrane Proteome Array technology to identify cell-surface proteins involved in regulating the ability of the human immune system to recognize and destroy cancer.
NextFab officially opens in Wilmington’s Creative District
NextFab, a collaborative makerspace network, officially has a new location in the heart of Wilmington’s Creative District, at 503 Tatnall St. Dozens of members of Delaware’s innovation community celebrated the opening at a Wednesday afternoon event.
Integral Molecular Announces the Expansion of Its Membrane Proteome Array Technology for Improving Antibody Safety and New Target Discovery
Integral Molecular announces the expansion of its proprietary Membrane Proteome Array™ to now consist of 5,300 unique human membrane proteins, representing nearly the entire human membrane proteome, making it the broadest platform of its kind for antibody specificity profiling and de-orphaning.